Dilatation and Evacuation Procedures and Second-Trimester Abortions: The Role of Physician Skill and Hospital Setting

JAMA: The Journal of the American Medical Association

Volumn 248, Issue 5, 1982, Pages 559-563

  Cates, Willard ^a   Schulz, Kenneth F ^a   Grimes, David A ^a   Horowitz, Arthur J ^b   Lyon, Fred A ^b   Kravitz, Fred H ^b   Frisch, Melvin J ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN F2 ALPHA;

EVACUATION; FEMALE GENITAL SYSTEM; INDUCED ABORTION; METHODOLOGY; PREGNANCY; THERAPY;

ABORTION, DRUG INDUCED--COMPLICATIONS; ABORTION, INDUCED; ABORTION, SALINE SOLUTION--COMPLICATIONS; AMERICAS; COMPARATIVE STUDIES; CURETTAGE--COMPLICATIONS; DEVELOPED COUNTRIES; FAMILY PLANNING; FAMILY PLANNING PERSONNEL; FERTILITY CONTROL, POSTCONCEPTION; HOSPITALS; MINNESOTA; NORTH AMERICA; NORTHERN AMERICA; OBSTETRICAL SURGERY; PHYSICIANS; PREGNANCY; PREGNANCY, SECOND TRIMESTER; REPRODUCTION; RESEARCH METHODOLOGY; STUDIES; SURGERY; TREATMENT; UNITED STATES; VACUUM ASPIRATION--COMPLICATIONS;

ABORTION, INDUCED; AMBULATORY CARE FACILITIES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CLINICAL COMPETENCE; EVALUATION STUDIES; FEMALE; HOSPITALIZATION; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY TRIMESTER, SECOND; RISK; UNITED STATES;

EID: 84944654892     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1982.03330050041028     Document Type: Article

References (37)

1. Hern WM: Midtrimester abortion, in Wynn RM (ed): Obstetrics and Gynecology Annual. New York, Appleton-Century-Crofts, 1981, pp 375-422.
2. Tyler CW, Cates W Jr, Schulz KF, et al.: Second trimester abortion in the United States, in Berger GS, Brenner WE, Keith L (eds): Second Trimester Abortion: Perspectives After a Decade of Experience. Littleton, Mass, PSG Publishing Co Inc, 1981, pp 13-26.
3. Abortion Surveillance, 1978. Atlanta, Centers for Disease Control, November 1980.
4. Grimes DA, Tyler CW Jr: Controversies concerning midtrimester dilatation and evacuation abortion, in Zuspan FP, Christian CD (eds): Controversies in Obstetrics and Gynecology. Philadelphia, WB Saunders Co, in press.
5. Cates W Jr, Schulz KF, Grimes DA, et al.: The effect of delay and choice of method on the risk of abortion morbidity. Fam Plann Perspect 1977;9:266-273.
6. Flowers CE: Discussion on hyperosmolar urea for midtrimester abortion. Am J Obstet Gynecol 1978;1311:14-15.
7. Altman A, Stubblefield PG, Parker K, et al.: Midtrimester abortion by laminaria and vacuum extraction on a teaching service: A review of 789 cases. Adv Planned Parenthood 1981;16:1-6.
8. Kaltreider NB, Goldsmith S, Margolis AJ: The impact of midtrimester abortion techniques on patients and staff. Am J Obstet Gynecol 1979;135:235-238.
9. Lindheim BL, Cotterill MA: Training in induced abortion by obstetrics and gynecology residency programs. Farn Plann Perspect 1978; 10:24-28.
10. Smith DH, Twigg HA, Craft IL: Prostaglandins in gel for mid-trimester abortion: A method to minimize nursing involvement. Br Med J 1981;282;2012.
11. Induced Abortion: Technical Reports Series 623. Geneva, World Health Organization, 1978.
12. Sylvester RJ, Pinedo HH, DePauw M, et al.: Quality of institutional participation in multicenter clinical trials. N Engl J Med 1981;305:852-855.
13. Schulz KF, Cates W Jr, Grimes DA, et al.: Reducing classification errors in cohort studies: The approach and a practical application. Statistics in Medicine, in press.
14. Thomas DG: Exact and asymptotic methods for the combination of 2×2 tables. Comput Biomed Res 1975;8:423-466.
15. Roe v Wade, 410 US113 (1973).
16. Horowitz AJ, Barr MM: Adjunctive use of laminaria tents with hypertonic saline induced mid-trimester abortion. Contraception 1974; 9:409-415.
17. Horowitz AJ: Pregnancy termination: Induction of mid-trimester abortion with intraamniotic injection of prostaglandin F2α. Minn Med 1977;60:509-512.
18. Horowitz AJ: Midtrimester abortion utilizing intra-amniotic prostaglandin F2α, laminaria and oxytocin. J Reprod Med 1978;21:236-240.
19. Grimes DA, Schulz KF, Cates W Jr, et al.: Midtrimester abortion by dilatation and evacuation: A safe and practical alternative. N Engl J Med 1977;296:1141-1145.
20. Tietze C, Lewit S: Joint Program for the Study of Abortion (JPSA): Early medical complications of legal abortion. Stud Fam Plann 1972;3:97-124.
21. Tietze C, Lewit S: Early medical complications of abortion by saline: Joint Program for the Study of Abortion (JPSA). Stud Fam Plann 1973;4:1333-1338.
22. Brenner WE, Edelman DA: Dilatation and evacuation at 13 to 15 weeks’ gestation versus intra-amniotic saline after 15 weeks’ gestation. Contraception 1974;10:171-180.
23. Smith RG, Steinhoff PG, Palmore JA: Potential reduction of medical complications from induced abortions. Int J Gynaecol Obstet 1978;15:337-346.
24. Hodari AA, Peralta J, Quiroga PJ, et al.: Dilatation and curettage for second trimester abortions. Am J Obstet Gynecol 1977;127:850-854.
25. Cadesky KI, Ravinsky E, Lyons ER: Dilation and evacuation: A preferred method of midtrimester abortion. Am J Obstet Gynecol 1981;139:329-332.
26. Grimes DA, Hulka JF, McCutchen ME: Midtrimester abortion by dilatation and evacuation versus intraamniotic instillation of prostaglandin F2α: A randomized clinical trial. Am J Obstet Gynecol 1980;137:785-790.
27. Grimes DA, Cates W Jr: Gestational age limit of 12 weeks for abortion by curettage. Am J Obstet Gynecol 1978;132:207-210.
28. Cates W Jr, Grimes DA: Deaths from second trimester abortion by dilatation and evacuation: Causes, prevention, facilities. Obstet Gynecol 1981;58:401-408.
29. Hern WM, Corrigan B: What about us? Staff reactions to D&E. Adv Planned Parenthood 1980;15:3-8.
30. Grimes DA, Schulz KF, Cates W Jr, et al.: Midtrimester abortion by intra-amniotic prostaglandin F2α: Safer than saline? Obstet Gynecol 1977;49:612-616.
31. Cohen E, Ballard CA: Consumptive coagulopathy associated with intraamniotic saline instillation and the effect of intravenous oxytocin. Obstet Gynecol 1974;43:300-303.
32. Berger GS, Edelman DA, Kerenyi TD: Oxytocin administration, instillation-to-abortion time, and morbidity associated with saline instillation. Am J Obstet Gynecol 1975;121:941-946.
33. Cates W Jr, Schulz KF: Oxytocin augmentation of second-trimester abortion: Safe or hazardous? Contraception 1980;22:513-525.
34. Grimes DA, Cates W Jr: The comparative efficacy and safety of intraamniotic prostaglandin F2α and hypertonic saline for second-trimester abortion: A review and critique. J Reprod Med 1979;22:248-254.
35. Hodgson JE, Portmann KC: Complications of 10,453 consecutive first-trimester abortions: A prospective study. Am J Obstet Gynecol 1974; 120:802-807.
36. Wulff GJL, Freiman SM: Elective abortion: Complications seen in a free-standing clinic. Obstet Gynecol 1977;49:351-357.
37. Bozorgi N: Statistical analysis of first-trimester pregnancy terminations in an ambulatory surgical center. Am J Obstet Gynecol 1977; 127:763-768.